Eagle Pharma Shares up After It Says Settlement Reached With Eli Lilly

Date : 12/13/2019 @ 8:37PM
Source : Dow Jones News
Stock : Eagle Pharmaceuticals Inc (EGRX)
Quote : 58.97  -0.58 (-0.97%) @ 1:00AM
After Hours
Last Trade
Last $ 58.97 ◊ 0.00 (0.00%)

Eagle Pharma Shares up After It Says Settlement Reached With Eli Lilly

Eagle Pharmaceuticals (NASDAQ:EGRX)
Historical Stock Chart

2 Months : From Nov 2019 to Jan 2020

Click Here for more Eagle Pharmaceuticals Charts.
   By Stephen Nakrosis 
 

Shares of Eagle Pharmaceuticals, Inc. (EGRX) are trading higher in Friday's market, after the company said it reached a settlement agreement with Eli Lilly and Co. (LLY) related to Pemfexy.

At 3:01 p.m. EST, Eagle Pharma shares had risen 2.77%, to trade at $60.78. The stock opened at $59.04 and earlier in the session fell as low as $58.54.

According to Eagle, the agreement releases all claims by all parties and allows for an initial entry of Pemfexy, a branded alternative to Alitma, into the market on February 1, 2022. Under the terms of the deal, Pemfexy will have an uncapped entry into the market on April 1 of that year, Eagle said.

 

--Write to Stephen Nakrosis at stephen.nakrosis@wsj.com

 

(END) Dow Jones Newswires

December 13, 2019 15:22 ET (20:22 GMT)

Copyright (c) 2019 Dow Jones & Company, Inc.

Latest EGRX Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts


Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.


NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.